SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kyung Uk Jung, Hee Cheol Kim, Joon Oh Park, Young Suk Park, Hee Chul Park, Doo Ho Choi, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Ho-Kyung Chun, Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: Is it necessary for all patients?, Journal of Surgical Oncology, 2015, 111, 4
  2. 2
    J. A. Cienfuegos, F. Rotellar, J. Baixauli, C. Beorlegui, J. J. Sola, L. Arbea, C. Pastor, J. Arredondo, J. L. Hernández-Lizoáin, Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery, Annals of Surgical Oncology, 2015, 22, 3, 916

    CrossRef

  3. 3
    K. Bujko, B. Glimelius, V. Valentini, W. Michalski, M. Spalek, Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin, European Journal of Surgical Oncology (EJSO), 2015,

    CrossRef

  4. 4
    Monirath Hav, Louis Libbrecht, Karen Geboes, Liesbeth Ferdinande, Tom Boterberg, Wim Ceelen, Piet Pattyn, Claude Cuvelier, Prognostic value of tumor shrinkage versus fragmentation following radiochemotherapy and surgery for rectal cancer, Virchows Archiv, 2015,

    CrossRef

  5. 5
    Chongjiao Li, Xiaoli Lan, Hui Yuan, Hongyan Feng, Xiaotian Xia, Yongxue Zhang, 18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis, Annals of Nuclear Medicine, 2014, 28, 5, 436

    CrossRef

  6. 6
    Sheng Li, Liangjun Zhu, Li Yao, Lei Xia, Liangxi Pan, Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy, BMC Gastroenterology, 2014, 14, 1, 154

    CrossRef

  7. 7
    A. Trakarnsanga, M. Gonen, J. Shia, G. M. Nash, L. K. Temple, J. G. Guillem, P. B. Paty, K. A. Goodman, A. Wu, M. Gollub, N. Segal, L. Saltz, J. Garcia-Aguilar, M. R. Weiser, Comparison of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After Multimodality Treatment, JNCI Journal of the National Cancer Institute, 2014, 106, 10, dju248

    CrossRef

  8. 8
    Martin R. Weiser, Do Improvements in Surgical Technique Mean it is Time to be more Selective in our Approach to Neoadjuvant Radiotherapy for Rectal Cancer?, Current Colorectal Cancer Reports, 2014, 10, 2, 173

    CrossRef

  9. 9
    F. Bibeau, C. Leaha, F. Boissière-Michot, P. Rouanet, Évaluation de la réponse histologique dans les cancers du rectum localement avancés après traitement néoadjuvant, Côlon & Rectum, 2014, 8, 1, 37

    CrossRef

  10. 10
    B. Rivière, M.-F. Jourdan, G. Goldman-Levy, F. Bibeau, Examen anatomopathologique des pièces de proctectomie après traitement néoadjuvant : description et impact de l’étape macroscopique, Côlon & Rectum, 2014, 8, 4, 224

    CrossRef

  11. 11
    Martin R. Weiser, Regina Beets-Tan, Gerard Beets, Management of Complete Response After Chemoradiation in Rectal Cancer, Surgical Oncology Clinics of North America, 2014, 23, 1, 113

    CrossRef

  12. 12
    Andreas M. Hötker, Julio Garcia-Aguilar, Marc J. Gollub, Multiparametric MRI of Rectal Cancer in the Assessment of Response to Therapy, Diseases of the Colon & Rectum, 2014, 57, 6, 790

    CrossRef

  13. 13
    Clarisse Eveno, Jeremie H. Lefevre, Magali Svrcek, Malika Bennis, Najim Chafai, Emmanuel Tiret, Yann Parc, Oncologic results after multivisceral resection of clinical T4 tumors, Surgery, 2014, 156, 3, 669

    CrossRef

  14. 14
    Aurélie Sannier, Jérémie H Lefèvre, Yves Panis, Dominique Cazals-Hatem, Pierre Bedossa, Nathalie Guedj, Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases, Histopathology, 2014, 65, 5
  15. 15
    R. Persiani, A. Biondi, M. A. Gambacorta, M. Bertucci Zoccali, F. M. Vecchio, A. Tufo, C. Coco, V. Valentini, G. B. Doglietto, D. D'Ugo, Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer, British Journal of Surgery, 2014, 101, 2
  16. 16
    Ailín C Rogers, David Gibbons, Ann M Hanly, John MP Hyland, P Ronan O'Connell, Desmond C Winter, Kieran Sheahan, Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy, Modern Pathology, 2014, 27, 1, 156

    CrossRef

  17. 17
    Marisa D. Santos, Cristina Silva, Anabela Rocha, Eduarda Matos, Carlos Nogueira, Carlos Lopes, Prognostic Value of Mandard and Dworak Tumor Regression Grading in Rectal Cancer: Study of a Single Tertiary Center, ISRN Surgery, 2014, 2014, 1

    CrossRef

  18. 18
    Whitney S. Brandt, Sherri Yong, Gerard Abood, Kenneth Micetich, Ashley Walther, Margo Shoup, The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection, The American Journal of Surgery, 2014, 207, 3, 357

    CrossRef

  19. 19
    Peng Gao, Yong-xi Song, Jing-xu Sun, Xiao-wan Chen, Ying-ying Xu, Jun-hua Zhao, Xuan-zhang Huang, Hui-mian Xu, Zhen-ning Wang, Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?, BMC Cancer, 2014, 14, 1, 888

    CrossRef

  20. 20
    Tawnya L. Bowles, Chung-Yuan Hu, Nancy Y. You, John M. Skibber, Miguel A. Rodriguez-Bigas, George J. Chang, An Individualized Conditional Survival Calculator for Patients with Rectal Cancer, Diseases of the Colon & Rectum, 2013, 56, 5, 551

    CrossRef

  21. 21
    Angelo Restivo, Luigi Zorcolo, Ivana Maria Francesca Cocco, Romina Manunza, Carla Margiani, Luigi Marongiu, Giuseppe Casula, Elevated CEA Levels and Low Distance of the Tumor from the Anal Verge are Predictors of Incomplete Response to Chemoradiation in Patients with Rectal Cancer, Annals of Surgical Oncology, 2013, 20, 3, 864

    CrossRef

  22. 22
    José G. Guillem, Jeannine A. Ruby, Tobias Leibold, Timothy J. Akhurst, Henry W. Yeung, Marc J. Gollub, Michelle S. Ginsberg, Jinru Shia, Arief A. Suriawinata, Elyn R. Riedel, Madhu Mazumdar, Leonard B. Saltz, Bruce D. Minsky, Garrett M. Nash, Philip B. Paty, Larissa K. Temple, Martin R. Weiser, Steven M. Larson, Neither FDG-PET Nor CT Can Distinguish Between a Pathological Complete Response and an Incomplete Response After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer, Annals of Surgery, 2013, 258, 2, 289

    CrossRef

  23. 23
    J. R. T. Monson, M. R. Weiser, W. D. Buie, G. J. Chang, J. F. Rafferty, W. Donald Buie, Janice Rafferty, Jose Guillem, Robin Boushey, George Chang, Daniel Feingold, Philip Fleshner, Jill Genua, Kerry Hammond, William Harb, Samantha Hendren, Daniel Herzig, Andreas Kaiser, David Larson, Sang Lee, James McCormick, Genevieve Melton-Meaux, Steven Mills, John Monson, Harvey Moore, W. Brian Perry, P. Terry Phang, David Rivadeneira, Howard Ross, Scott Steele, Scott Strong, Charles Ternent, Madhulika Varma, Martin Weiser, Kirsten Wilkins, Practice Parameters for the Management of Rectal Cancer (Revised), Diseases of the Colon & Rectum, 2013, 56, 5, 535

    CrossRef

  24. 24
    Emily Steinhagen, Jinru Shia, Elyn Riedel, Garrett M. Nash, Martin R. Weiser, Larissa K. Temple, Phillip B. Paty, José G. Guillem, Response to Neoadjuvant Therapy in Patients With Early Age-of-Onset Rectal Cancer, Diseases of the Colon & Rectum, 2013, 56, 1, 58

    CrossRef

  25. 25
    Rodrigo Oliva Perez, Angelita Habr-Gama, Patricio Bernardo Lynn, Guilherme Pagin São Julião, Romina Bianchi, Igor Proscurshim, Joaquim Gama-Rodrigues, Transanal Endoscopic Microsurgery for Residual Rectal Cancer (ypT0-2) Following Neoadjuvant Chemoradiation Therapy, Diseases of the Colon & Rectum, 2013, 56, 1, 6

    CrossRef

  26. 26
    Angelita Habr-Gama, Jorge Sabbaga, Joaquim Gama-Rodrigues, Guilherme P. São Julião, Igor Proscurshim, Patricia Bailão Aguilar, Wladimir Nadalin, Rodrigo O. Perez, Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer, Diseases of the Colon & Rectum, 2013, 56, 10, 1109

    CrossRef

  27. 27
    Atthaphorn Trakarnsanga, Mithat Gonen, Jinru Shia, Karyn A. Goodman, Garrett M. Nash, Larissa K. Temple, José G. Guillem, Philip B. Paty, Julio Garcia-Aguilar, Martin R. Weiser, What is the Significance of the Circumferential Margin in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy?, Annals of Surgical Oncology, 2013, 20, 4, 1179

    CrossRef

  28. 28
    Sang Hui Moon, Dae Yong Kim, Ji Won Park, Jae Hwan Oh, Hee Jin Chang, Sun Young Kim, Tae Hyun Kim, Hee Chul Park, Doo Ho Choi, Ho-Kyung Chun, Jong Hoon Kim, Jin-hong Park, Chang Sik Yu, Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?, Cancer, 2012, 118, 20
  29. 29
    Luigi Zorcolo, Alan S. Rosman, Angelo Restivo, Michele Pisano, Giuseppe R. Nigri, Alessandro Fancellu, Marcovalerio Melis, Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis, Annals of Surgical Oncology, 2012, 19, 9, 2822

    CrossRef

  30. 30
    M. J. Gollub, D. H. Gultekin, O. Akin, R. K. Do, J. L. Fuqua, M. Gonen, D. Kuk, M. Weiser, L. Saltz, D. Schrag, K. Goodman, P. Paty, J. Guillem, G. M. Nash, L. Temple, J. Shia, L. H. Schwartz, Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer, European Radiology, 2012, 22, 4, 821

    CrossRef

  31. 31
    Jeannine A. Ruby, Tobias Leibold, Timothy J. Akhurst, Jinru Shia, Leonard B. Saltz, Madhu Mazumdar, Elyn R. Riedel, Steven M. Larson, José G. Guillem, FDG-PET Assessment of Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Is Not Associated With Long-Term Prognosis, Diseases of the Colon & Rectum, 2012, 55, 4, 378

    CrossRef

  32. 32
    Runjan Chetty, Pelvender Gill, Dhirendra Govender, Adrian Bateman, Hee Jin Chang, Vikram Deshpande, David Driman, Marisa Gomez, Godman Greywoode, Eleanor Jaynes, C. Soon Lee, Michael Locketz, Corwyn Rowsell, Anne Rullier, Stefano Serra, Neil Shepherd, Eva Szentgyorgyi, Rajkumar Vajpeyi, Lai Mun Wang, Andrew Bateman, International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems, Human Pathology, 2012, 43, 11, 1917

    CrossRef

  33. 33
    Ravi P. Kiran, Hasan T. Kirat, Adele N. Burgess, Pasha J. Nisar, Matthew F. Kalady, Ian C. Lavery, Is Adjuvant Chemotherapy Really Needed After Curative Surgery for Rectal Cancer Patients Who are Node-Negative After Neoadjuvant Chemoradiotherapy?, Annals of Surgical Oncology, 2012, 19, 4, 1206

    CrossRef

  34. 34
    J. D. Smith, G. M. Nash, M. R. Weiser, L. K. Temple, J. G. Guillem, P. B. Paty, Multivisceral resections for rectal cancer, British Journal of Surgery, 2012, 99, 8
  35. 35
    L. Maggiori, Y. Panis, Quelles sont les bonnes indications de radiochimiothérapie dans le cancer du rectum ?, Côlon & Rectum, 2012, 6, 2, 74

    CrossRef

  36. You have free access to this content36
    Lauren Kosinski, Angelita Habr-Gama, Kirk Ludwig, Rodrigo Perez, Shifting concepts in rectal cancer management, CA: A Cancer Journal for Clinicians, 2012, 62, 3
  37. 37
    Seung-Gu Yeo, Dae Yong Kim, Ji Won Park, Hyo Seong Choi, Jae Hwan Oh, Sun Young Kim, Hee Jin Chang, Tae Hyun Kim, Dae Kyung Sohn, Stage-to-Stage Comparison of Preoperative and Postoperative Chemoradiotherapy for T3 Mid or Distal Rectal Cancer, International Journal of Radiation Oncology*Biology*Physics, 2012, 82, 2, 856

    CrossRef

  38. 38
    Eric D. Miller, Bruce W. Robb, Oscar W. Cummings, Peter A. S. Johnstone, The Effects of Preoperative Chemoradiotherapy on Lymph Node Sampling in Rectal Cancer, Diseases of the Colon & Rectum, 2012, 55, 9, 1002

    CrossRef

  39. 39
    Chiara Molinari, Michela Ballardini, Nazario Teodorani, Massimo Giannini, Wainer Zoli, Ermanno Emiliani, Enrico Lucci, Alessandro Passardi, Paola Rosetti, Luca Saragoni, Massimo Guidoboni, Dino Amadori, Daniele Calistri, Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study, Radiation Oncology, 2011, 6, 1, 161

    CrossRef

  40. 40
    Seog Yun Park, Hee Jin Chang, Dae Yong Kim, Kyung Hae Jung, Sun Young Kim, Ji Won Park, Jae Hwan Oh, Seok-Byung Lim, Hyo Seong Choi, Seung-Yong Jeong, Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?, Histopathology, 2011, 59, 4
  41. 41
    J. M. C. Yeung, V. Kalff, R. J. Hicks, E. Drummond, E. Link, Y. Taouk, M. Michael, S. Ngan, A. C. Lynch, A. G. Heriot, Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome, Diseases of the Colon & Rectum, 2011, 54, 5, 518

    CrossRef

  42. 42
    Ingrid Garajová, Stefania Di Girolamo, Francesco de Rosa, Jody Corbelli, Valentina Agostini, Guido Biasco, Giovanni Brandi, Neoadjuvant Treatment in Rectal Cancer: Actual Status, Chemotherapy Research and Practice, 2011, 2011, 1

    CrossRef

  43. 43
    Jung Wook Huh, Chang Hyun Kim, Hyeong Rok Kim, Young Jin Kim, Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: Are they comparable?, Surgery, 2011, 150, 5, 980

    CrossRef

  44. 44
    Huankai Hu, Alyssa Krasinskas, Joseph Willis, Perspectives on Current Tumor-Node-Metastasis (TNM) Staging of Cancers of the Colon and Rectum, Seminars in Oncology, 2011, 38, 4, 500

    CrossRef

  45. 45
    Rodrigo Oliva Perez, Predicting Response to Neoadjuvant Treatment for Rectal Cancer: A Step Toward Individualized Medicine, Diseases of the Colon & Rectum, 2011, 54, 9, 1057

    CrossRef

  46. 46
    Frédéric Bibeau, Anne Rullier, Marie-Françoise Jourdan, Hélène Frugier, Julien Palasse, Cristina Leaha, Amélie Gudin de Vallerin, Benjamin Rivière, Xavier Bodin, Véronique Perrault, Céline Cantos, Roselyne Lavaill, Florence Boissière-Michot, David Azria, Pierre-Emmanuel Colombo, Philippe Rouanet, Éric Rullier, Yves Panis, Nathalie Guedj, Prise en charge des cancers du rectum localement avancés : quel rôle pour le pathologiste en 2011 ?, Annales de Pathologie, 2011, 31, 6, 433

    CrossRef

  47. 47
    Anand Govindarajan, Diane Reidy, Martin R. Weiser, Philip B. Paty, Larissa K. Temple, Jose G. Guillem, Leonard B. Saltz, W. Douglas Wong, Garrett M. Nash, Recurrence Rates and Prognostic Factors in ypN0 Rectal Cancer After Neoadjuvant Chemoradiation and Total Mesorectal Excision, Annals of Surgical Oncology, 2011, 18, 13, 3666

    CrossRef

  48. 48
    Jin-Tung Liang, Hong-Shiee Lai, Kuo-Wei Cheng, Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX, Surgical Endoscopy, 2011, 25, 1, 305

    CrossRef

  49. 49
    Giacomo Puppa, TNM staging system of colorectal carcinoma: surgical pathology of the seventh edition, Diagnostic Histopathology, 2011, 17, 6, 243

    CrossRef

  50. 50
    Garrett M. Nash, Alexander Weiss, Roshni Dasgupta, Mithat Gonen, Jose G. Guillem, W. Douglas Wong, Close Distal Margin and Rectal Cancer Recurrence After Sphincter-Preserving Rectal Resection, Diseases of the Colon & Rectum, 2010, 53, 10, 1365

    CrossRef

  51. 51
    Angelita Habr-Gama, Rodrigo Perez, Igor Proscurshim, Joaquim Gama-Rodrigues, Complete Clinical Response after Neoadjuvant Chemoradiation for Distal Rectal Cancer, Surgical Oncology Clinics of North America, 2010, 19, 4, 829

    CrossRef

  52. 52
    Angelita Habr-Gama, Rodrigo O. Perez, Gregory Wynn, John Marks, Hermann Kessler, Joaquim Gama-Rodrigues, Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for Standardization, Diseases of the Colon & Rectum, 2010, 53, 12, 1692

    CrossRef

  53. 53
    K. Bujko, R. Glynne-Jones, M. Bujko, Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials, Annals of Oncology, 2010, 21, 9, 1743

    CrossRef

  54. 54
    Luiz Felipe de Campos-Lobato, Luca Stocchi, Andre da Luz Moreira, Matthew F. Kalady, Daniel Geisler, David Dietz, Ian C. Lavery, Feza H. Remzi, Victor W. Fazio, Downstaging Without Complete Pathologic Response After Neoadjuvant Treatment Improves Cancer Outcomes for cIII but not cII Rectal Cancers, Annals of Surgical Oncology, 2010, 17, 7, 1758

    CrossRef

  55. 55
    Monique Maas, Patty J Nelemans, Vincenzo Valentini, Prajnan Das, Claus Rödel, Li-Jen Kuo, Felipe A Calvo, Julio García-Aguilar, Rob Glynne-Jones, Karin Haustermans, Mohammed Mohiuddin, Salvatore Pucciarelli, William Small, Javier Suárez, George Theodoropoulos, Sebastiano Biondo, Regina GH Beets-Tan, Geerard L Beets, Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, The Lancet Oncology, 2010, 11, 9, 835

    CrossRef

  56. 56
    Eric J. Silberfein, Kiran M. Kattepogu, Chung-Yuan Hu, John M. Skibber, Miguel A. Rodriguez-Bigas, Barry Feig, Prajnan Das, Sunil Krishnan, Christopher Crane, Scott Kopetz, Cathy Eng, George J. Chang, Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer, Annals of Surgical Oncology, 2010, 17, 11, 2863

    CrossRef

  57. 57
    T. Liersch, J. Gaedcke, M. Grade, T. Sprenger, L. Conradi, H. Becker, B.M. Ghadimi, Molekulare Marker zur Responseprädiktion beim lokal fortgeschrittenen Rektumkarzinom, Der Onkologe, 2010, 16, 8, 779

    CrossRef

  58. 58
    Asunción Hervás Morón, María Luisa García de Paredes, Eduardo Lobo Martínez, Multidisciplinary management in rectal cancer, Clinical and Translational Oncology, 2010, 12, 12, 805

    CrossRef

  59. 59
    Jill Moore, Kimberly A. Jones, Douglas G. Adler, Management of rectal cancer: part II, Community Oncology, 2009, 6, 6, 265

    CrossRef

  60. 60
    R.W. Byhardt, Pathologic Stage Is Most Prognostic of Disease-free Survival in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiation, Yearbook of Oncology, 2009, 2009, 147

    CrossRef

  61. 61
    Matthew F. Kalady, Luiz Felipe de Campos-Lobato, Luca Stocchi, Daniel P. Geisler, David Dietz, Ian C. Lavery, Victor W. Fazio, Predictive Factors of Pathologic Complete Response After Neoadjuvant Chemoradiation for Rectal Cancer, Transactions of the ... Meeting of the American Surgical Association, 2009, 127, 213

    CrossRef

  62. 62
    Martin R. Weiser, Hak-Mien Quah, Jinru Shia, José G. Guillem, Philip B. Paty, Larissa K. Temple, Karyn A. Goodman, Bruce D. Minsky, W Douglas Wong, Sphincter Preservation in Low Rectal Cancer is Facilitated by Preoperative Chemoradiation and Intersphincteric Dissection, Annals of Surgery, 2009, 249, 2, 236

    CrossRef

  63. 63
    Prajnan Das, Christopher H. Crane, Staging, prognostic factors, and therapy of localized rectal cancer, Current Oncology Reports, 2009, 11, 3, 167

    CrossRef

  64. 64
    Karoline Horisberger, Philipp Erben, Benjamin Muessle, Christoph Woernle, Philipp Stroebel, Georg Kaehler, Frederik Wenz, Andreas Hochhaus, Stefan Post, Frank Willeke, Ralf-Dieter Hofheinz, Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer, Anti-Cancer Drugs, 2009, 20, 6, 519

    CrossRef

  65. 65
    D. Beddy, J. M. P. Hyland, D. C. Winter, C. Lim, A. White, M. Moriarty, J. Armstrong, D. Fennelly, D. Gibbons, K. Sheahan, A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy, Annals of Surgical Oncology, 2008, 15, 12, 3471

    CrossRef